RecruitingNot Applicable

Finishing HIV Project

United States624 participantsStarted 2024-11-08

Plain-language summary

This study aims to learn how to help enable healthy behaviors and lower the risk of HIV among Latinx Men.

Age range18 Years – 54 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Provision of signed and dated informed consent form
✓. Stated willingness to comply with all study procedures and availability for the duration of the study
✓. Being 18 to 54 years of age
✓. Being a cis-gender male
✓. Self-report one or more of the following behaviors and health conditions in the last 6 months which meet the Centers for Disease Control and Prevention (CDC) clinical guidelines for PrEP eligibility
✓. Self-reported status as HIV negative
✓. Willing to be tested for HIV

✕. Display diminished capacity to consent because of:
✕. \<18 years old or \>54 years old
✕. Self-reported living with HIV
✕. Reactive HIV test (for "Amigx" seeds or "Yo Quiero" control participants)
✕. Refusal of HIV test
✕. Identifies as Non-Latinx
✕. Individuals enrolled in other PrEP initiation interventions
✕. Individuals with an active PrEP prescription in the last 6-months (oral or injectable)

Number of participants that report using PrEP

Timeframe: Up to 12-months

Number of Dried Blood Spot (DBS) tests that report PrEP use

Timeframe: Up to 12-months

Number of participants that bring a proof of PrEP prescription

Timeframe: Up to 12-months

NCT IDNCT06406049

SponsorUniversity of Miami

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2030-05-31

Mariano Kanamori, PhD